Asthma  >>  Dulera (mometasone/formoterol)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dulera (mometasone/formoterol) / Merck (MSD), Novartis
NCT00746330: Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma

Completed
2
32
US, RoW
Mometasone furoate/formoterol fumarate (MFF), Formoterol fumarate 12 μg pMDI (F12M), Formoterol fumarate 12 μg DPI (F12D), Placebo to F12D, Placebo to F12M/MFF
Novartis, Schering-Plough
Asthma
04/09
04/09
NCT00635882 / 2007-001959-19: Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)

Completed
2
93
NA
mometasone furoate/formoterol 100/10 mcg, MF/F (SCH 418131), mometasone furoate/formoterol 200/10 mcg, MF/F 200/10 (SCH 418131), mometasone furoate/formoterol 400/10 mcg, MF/F 400/10 (SCH 418131), MF DPI 200 mcg, mometasone furoate (SCH 32088), MF MDI 200 mcg, Placebo
Organon and Co
Asthma, Airway Inflammation
06/09
06/09
MK-0887A-178, NCT01258803 / 2014-004582-24: A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)

Completed
2
92
NA
Formoterol Fumarate DPI, SCH 045571, MK-5571, Foradil® Aerolizer®, Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer, SCH 418131, MK-0877A, Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) with spacer, Placebo MDI with spacer, Placebo MDI without spacer, Mometasone Furoate DPI, SCH 032088, MK-0887, Asmanex® Twisthaler®
Organon and Co
Asthma
10/11
10/11
NCT01615874 / 2009-010108-27: Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

Withdrawn
2
0
NA
MF/F Metered Dose Inhaler (MDI) 25/5 mcg, SCH 418131, MK-0887A, DULERA®, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg, BDP hydrofluoroalkane (HFA) 80 mcg, BECONASE AQ®, QVAR®, Montelukast tablets 5 mg (4 mg for children 5 years of age), MK-0476, SINGULAIR®, Rescue medication: short-acting beta-2 agonist (SABA) MDI, Rescue medication: Prednisone/Prednisolone
Organon and Co
Asthma
09/13
09/13
EXPEDITION, NCT02573233 / 2015-001572-22: Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

Checkmark From EXPEDITION trial
Jan 2019 - Jan 2019: From EXPEDITION trial
Completed
2
42
Europe, Canada, US
Placebo, Dupilumab SAR231893/REGN668, fluticasone propionate and salmeterol, Advair, budesonide and formoterol, Symbicort, mometasone furoate and formoterol, Dulera
Sanofi, Regeneron Pharmaceuticals
Asthma
01/18
01/18
NCT04179461: Personalized Treatment Algorithms for Difficult-to-treat Asthma

Completed
2
21
US
Cholecalciferol, Vitamin D, antihistamine, cetirizine, loratadine, Azithromycin, Zithromax, emollient cream, Fluticasone Propionate, Flonase Nasal Spray, Asthma Controller Medication, Mometasone/Formoterol, Fluticasone/Salmeterol, Mometasone Furoate, Fluticasone, Beclomethasone, Budesonide/Formoterol, Tiotropium
Children's Hospital Medical Center, Cincinnati
Asthma in Children
10/19
10/19

Download Options